CD4 and encephalomyelitis: Interestingly, Tamoxifen-treated Cre-ERT2-Gata3fl/fl CD4 effector cells Tcra-/- recipients were resistant to transfer EAE in comparison to vehicle treated controls (Figure 4C), indicating that late maintenance levels of GATA3 are also required for Th17-mediated encephalomyelitis.